Delivery Order SPE2DB20D3303-SPE2DB24FA0RB

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of febuxostat 40 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,204.34. The contract has an ultimate completion date of August 7, 2024 and is a firm fixed-price delivery order. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
The U.S. Defense Logistics Agency (DLA) awarded a $1,518.00 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,497,445 units of Febuxostat 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The contract is for the delivery of 4,564,375,688 units of the pharmaceutical product febuxostat 40 mg tablet in 30-count packages, with a total ceiling value of $2,957.55. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical drug febuxostat 40 mg tablets in 30-count packages. The contract, valued at $1,897.50, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier, to provide FEBUXOSTAT 40 MG TABLET 30S. The fixed-price contract has a ceiling value of $1,138.50 and an ultimate completion date of July 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4,566,025 units of the drug febuxostat 40 mg tablets. The delivery order contract, valued at $1,624.68, has a firm fixed price and an ultimate completion date of October 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award is for the delivery of Febuxostat 40 mg tablets, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $3,415.97, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a Firm Fixed Price delivery order contract. The contract has a completion date of March 18, 2024 and does not have a set-aside designation, indicating it was awarded through full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,831.46 firm fixed price delivery order is for the supply of 4,564,382,658 units of the pharmaceutical product FEBUXOSTAT 40 MG TABLET 30S. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the prescription medication febuxostat 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has a total ceiling value of $1,863.84 and is a firm fixed-price delivery order, with a period of performance through June 5, 2024. As a major supplier of pharmaceutical products and medical supplies to the federal government,...
This federal contract award is for the delivery of Febuxostat 40 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $2,136.51, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order and has a firm fixed price pricing type, with a performance period ending on March 3, 2023. The award was made without any set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA0RB
    Delivery Order

This federal contract award is for the delivery of 4,565,056,304 units of the pharmaceutical product febuxostat 40 mg tablets, in a 30-count supply, to the Defense Logistics Agency (DLA). The total ceiling value of the contract is $2,475.34, with a firm fixed price pricing type. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award is not designated as a set-aside contract.

Generated 10/1/24, 10:45 AM